# EDGAR Filing Document

**Accession Number:** 0002033227
**File Stem:** 0001099910-26-000148
**Filing Date:** 2026-4
**Character Count:** 18269
**Document Hash:** c6986753f6c0aa014e8ead268e20a727
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001099910-26-000148.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0001099910-26-000148

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BranchOut Food Inc.
- **CENTRAL INDEX KEY:** 0001962481
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 873980472
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94512
- **FILM NUMBER:** 26840726

**BUSINESS ADDRESS:**
- **STREET 1:** 205 SE DAVIS AVENUE,
- **STREET 2:** SUITE C
- **CITY:** BEND
- **STATE:** OR
- **ZIP:** 97702
- **BUSINESS PHONE:** 844-263-6637

**MAIL ADDRESS:**
- **STREET 1:** 205 SE DAVIS AVENUE,
- **STREET 2:** SUITE C
- **CITY:** BEND
- **STATE:** OR
- **ZIP:** 97702
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kaufman Kapital LLC
- **CENTRAL INDEX KEY:** 0002033227

**ORGANIZATION NAME:**
- **EIN:** 994077921
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2158 PARK BOULEVARD
- **CITY:** SAN JUAN
- **PROVINCE COUNTRY:** PR
- **BUSINESS PHONE:** 786-835-5992

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2158 PARK BOULEVARD
- **CITY:** SAN JUAN
- **PROVINCE COUNTRY:** PR

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**BranchOut Food Inc.**

*(Name of Issuer)*

**Common Stock, $0.001 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Daniel L. Kaufman**<br>2158 Park Boulevard<br>San Juan PR 00913<br>(802) 368-5885

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/06/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Kaufman Kapital LLC** | Name of reporting person<br>**Kaufman Kapital LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6813306.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6813306.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6813306.00** | Aggregate amount beneficially owned by each reporting person<br>**6813306.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**34.5%** | Percent of class represented by amount in Row (11)<br>**34.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** 1 This amount includes (i) 1,659,457 shares of Common Stock held directly, (ii) 3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at $0.7582 per share, (iii) 829,001 shares of Common Stock issuable upon conversion of approximately $628,600 of accrued and unpaid interest under the Convertible Note at $0.7582 per share, and (iv) 500,000 shares of Common Stock issuable upon exercise of the $1.50 Warrant. Interest continues to accrue at 12% per annum on $2,900,000 of outstanding principal.

2 The percentage is calculated based upon a denominator that includes (i) 14,582,416 shares outstanding as of March 25, 2026 (as reported in the Issuer's Annual Report on Form 10-K filed March 31, 2026) and (ii) an aggregate of 5,153,849 shares issuable upon conversion and exercise of derivative securities held by the Reporting Persons.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Daniel Louis Kaufman** | Name of reporting person<br>**Daniel Louis Kaufman** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6813306.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6813306.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6813306.00** | Aggregate amount beneficially owned by each reporting person<br>**6813306.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**34.5%** | Percent of class represented by amount in Row (11)<br>**34.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** 1 This amount includes (i) 1,659,457 shares of Common Stock held directly, (ii) 3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at $0.7582 per share, (iii) 829,001 shares of Common Stock issuable upon conversion of approximately $628,600 of accrued and unpaid interest under the Convertible Note at $0.7582 per share, and (iv) 500,000 shares of Common Stock issuable upon exercise of the $1.50 Warrant. Interest continues to accrue at 12% per annum on $2,900,000 of outstanding principal.

2 The percentage is calculated based upon a denominator that includes (i) 14,582,416 shares outstanding as of March 25, 2026 (as reported in the Issuer's Annual Report on Form 10-K filed March 31, 2026) and (ii) an aggregate of 5,153,849 shares issuable upon conversion and exercise of derivative securities held by the Reporting Persons.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.001 par value per share

**(b) Name of Issuer:**
BranchOut Food Inc.

**(c) Address of Issuer's Principal Executive Offices:**
205 SE DAVIS AVENUE,, SUITE C, BEND, OR, 97702

EXPLANATORY NOTE

This Amendment No. 2 to Schedule 13D (this "Amendment") amends and supplements the Schedule 13D filed on October 17, 2024 (the "Original 13D"), as amended by Amendment No. 1 filed on December 11, 2024 ("Amendment No. 1," and together with the Original 13D, as amended, the "Schedule 13D"), by Daniel L. Kaufman ("Kaufman") and Kaufman Kapital LLC ("Kaufman Kapital," and together with Kaufman, the "Reporting Persons") with respect to the common stock, $0.001 par value per share (the "Common Stock"), of BranchOut Food Inc., a Nevada corporation (the "Issuer"). The Original 13D was filed upon the Reporting Persons' transition from Schedule 13G (initially filed August 8, 2024) to Schedule 13D following shareholder approval on October 14, 2024 of the issuance of shares in excess of the Nasdaq 19.9% limit.

This Amendment is being filed to report (i) the exercise by Kaufman Kapital of a warrant to purchase 1,000,000 shares of Common Stock on June 5, 2025, (ii) the entry by Kaufman Kapital and the Issuer into a Warrant Exercise and Amendment to Notes and Warrant Agreement on June 1, 2025, (iii) the conversion by Kaufman Kapital of $500,000 of principal under the Convertible Note (as defined below) into 659,457 shares of Common Stock on January 28, 2026, (iv) the issuance by the Issuer of a new Senior Secured Promissory Note to Kaufman Kapital on January 28, 2026, (v) the repayment in full of a prior Senior Secured Promissory Note, and (vi) updates to Items 2, 3, 4, 5 and 6 of the Schedule 13D. Except as specifically amended and supplemented hereby, the Schedule 13D remains in full force and effect.

**Item 4. Purpose of Transaction**

Item 4 of the Schedule 13D is hereby amended and restated in its entirety, and supersedes and replaces in its entirety the Item 4 disclosure in the Original 13D and Amendment No. 1, as follows:

June 2025 Warrant Exercise and Amendment. On June 1, 2025, Kaufman Kapital and the Issuer entered into a Warrant Exercise and Amendment to Notes and Warrant Agreement (the "June 2025 Amendment"), pursuant to which: (i) Kaufman Kapital agreed to exercise the $1.00 Warrant in full for $1,000,000 cash, (ii) the expiration date of the warrant to purchase 500,000 shares of Common Stock at $1.50 per share (the "$1.50 Warrant") was extended from December 31, 2025 to December 31, 2026, (iii) the maturity date of the Convertible Note was extended from December 31, 2025 to December 31, 2026, (iv) the maturity date of the Prior Secured Note was extended to December 31, 2025, and (v) the Issuer agreed not to prepay more than $2,400,000 of principal outstanding under the Convertible Note prior to September 30, 2026 and not to make any prepayment under the Convertible Note while amounts remain outstanding under any non-convertible notes of the Issuer (excluding notes issued pursuant to equipment financing). A copy of the June 2025 Amendment was filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed on June 2, 2025 and is incorporated herein by reference.

January 2026 Conversion. On January 28, 2026, Kaufman Kapital converted $500,000 of outstanding principal under the Convertible Note into 659,457 shares of Common Stock at the fixed conversion price of $0.7582 per share.

January 2026 New Loan. On January 28, 2026, Kaufman Kapital loaned $1,500,000 to the Issuer pursuant to the New Secured Note.

Current Plans and Purposes. The Reporting Persons currently hold the securities of the Issuer for investment purposes. The Reporting Persons continuously evaluate their investment in the Issuer based on a variety of factors, including the Issuer's financial condition, results of operations, business prospects, general market and economic conditions, and other factors. Depending on such evaluation, the Reporting Persons may from time to time acquire additional securities of the Issuer (including through conversion of outstanding Convertible Note principal and accrued interest or exercise of the $1.50 Warrant), dispose of some or all of the securities of the Issuer (including through open-market sales, privately negotiated transactions, block trades, registered offerings, or otherwise), or take any other action with respect to their investment in the Issuer as they may deem appropriate. Any such transactions may be effected at any time and from time to time, without prior notice, and will depend upon a variety of factors, including those described above.

Except as otherwise described in this Amendment, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a)-(b)  As of the date of this Amendment, the Reporting Persons may be deemed to beneficially own an aggregate of 6,813,306 shares of Common Stock, consisting of:

**(b)**
(i)  1,659,457 shares of Common Stock held directly by Kaufman Kapital, consisting of 1,000,000 shares acquired upon exercise of the $1.00 Warrant on June 5, 2025, and 659,457 shares acquired upon conversion of $500,000 of Convertible Note principal on January 28, 2026;

(ii)  3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at the fixed conversion price of $0.7582 per share;

(iii)  829,001 shares of Common Stock issuable upon conversion of approximately $628,600 of accrued and unpaid interest under the Convertible Note as of the date hereof, at the fixed conversion price of $0.7582 per share (interest continues to accrue at the rate of 12% per annum on $2,900,000 of outstanding principal); and

(iv)  500,000 shares of Common Stock issuable upon exercise of the $1.50 Warrant at $1.50 per share.

The percentage of Common Stock beneficially owned is calculated in accordance with Rule 13d-3 under the Exchange Act based upon a denominator that includes (i) 14,582,416 shares of Common Stock outstanding as of March 25, 2026, as reported in the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 31, 2026, and (ii) an aggregate of 5,153,849 shares issuable upon conversion and exercise of derivative securities held by the Reporting Persons that are convertible or exercisable within 60 days, for a total denominator of 19,736,265 shares.

Kaufman, as the sole member and manager of Kaufman Kapital, has sole voting and dispositive power over all securities held by Kaufman Kapital. Kaufman does not directly own any shares of Common Stock.

**(c)**
No transactions in the Common Stock were effected by the Reporting Persons during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

In addition to the agreements previously disclosed in the Schedule 13D, the Reporting Persons are parties to the following agreements:

Warrant Exercise and Amendment to Notes and Warrant Agreement, dated June 1, 2025, between Kaufman Kapital and the Issuer, pursuant to which, among other things, Kaufman Kapital exercised the $1.00 Warrant in full, the expiration date of the $1.50 Warrant was extended to December 31, 2026, the maturity date of the Convertible Note was extended to December 31, 2026, the maturity date of the Prior Secured Note was extended to December 31, 2025, and the Issuer agreed to certain restrictions on prepayment of the Convertible Note. A copy of this agreement was filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed on June 2, 2025.

Senior Secured Promissory Note, dated January 28, 2026, in the principal amount of $1,500,000, issued by the Issuer to Kaufman Kapital. The New Secured Note bears interest at 8% per annum, matures on January 28, 2027, and is secured by a lien on substantially all of the Issuer's assets pursuant to the Security Agreement. The New Secured Note is not convertible into Common Stock. A copy of the New Secured Note was filed as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed on January 28, 2026.

The Convertible Note, as amended, continues to be outstanding with a remaining principal balance of $2,900,000 and approximately $628,600 of accrued and unpaid interest as of the date hereof. The Convertible Note bears interest at 12% per annum, matures on December 31, 2026, and is convertible at any time at the option of the holder at a fixed conversion price of $0.7582 per share. Both outstanding principal and accrued interest are convertible into Common Stock. The Issuer's obligations under the Convertible Note continue to be secured by a lien on substantially all of the Issuer's assets pursuant to the Security Agreement.

The $1.50 Warrant remains outstanding and is exercisable for 500,000 shares of Common Stock at $1.50 per share through December 31, 2026.

The Prior Secured Note has been repaid in full and is no longer outstanding.

Except as described above and in the documents previously filed with the Schedule 13D, the Reporting Persons do not have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to the securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Kaufman Kapital LLC

**Signature:** Daniel L. Kaufman

**Name/Title:** Sole Member and Manager

**Date:** 04/06/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Daniel Louis Kaufman

**Signature:** Daniel Louis Kaufman

**Name/Title:** Daniel Louis Kaufman, individually

**Date:** 04/06/2026